FDA Adverse Event Malfunction Summary report: N

ID NOW COVID-19 ASSAY

MDR report key: 11678625 · Received April 16, 2021

Report

Report Number
1221359-2021-01007
Event Type
Malfunction
Date Received
April 16, 2021
Date of Event
March 13, 2021
Report Date
May 27, 2021
Manufacturer
ABBOTT DIAGNOSTICS SCARBOROUGH, INC
Product Code
QJR
UDI-DI
10811877011269
PMA / PMN Number
EUA2000074
Report Source
Manufacturer report
Reporter Location
HI, US
Reporter Occupation
501

Narratives

Additional Manufacturer Narrative · 0

ADDITIONAL INFORMATION: H10: TESTING WAS PERFORMED AT ABBOTT DIAGNOSTICS SCARBOROUGH, INC. ON RETAINED KIT LOT 1023084 WITH INTERNAL POSITIVE QUALITY CONTROL SAMPLES AND NEGATIVE QUALITY CONTROL SWABS. ALL TEST RESULTS WERE VALID AND PERFORMED AS EXPECTED. ADDITIONALLY, THE MANUFACTURING RECORDS AND QUALITY CONTROL RELEASE TESTING WAS REVIEWED FOR TEST KIT PART NUMBER 190-000 / LOT: 1023084, TEST BASE PART NUMBER 190-430 / LOT: 1023084. THE LOT MET THE REQUIRED RELEASE SPECIFICATIONS. A REVIEW OF THE COMPLAINTS REPORTED AS FALSE POSITIVE PATIENT RESULTS (CONFIRMED AND UNCONFIRMED, CONFLICTING RESULTS) RELATED TO KIT LOT 1023084 SHOWED THAT THE COMPLAINT RATE IS (B)(4). ABBOTT DIAGNOSTICS SCARBOROUGH WAS UNABLE TO DETERMINE THE EXACT ROOT CAUSE OF THE REPORTED ISSUE; HOWEVER IT COULD POSSIBLY BE RELATED TO THE SPECIFIC PATIENT SAMPLE.

Additional Manufacturer Narrative · 1

THIS INVESTIGATION IS STILL IN PROGRESS. ONCE THE INVESTIGATION IS COMPLETE A SUPPLEMENTAL REPORT WILL BE PROVIDED. REFERENCE MFR REPORTS: 1221359-2021-00872 1221359-2021-01006.

Description of Event or Problem · 1

THE CUSTOMER REPORTED FALSE POSITIVE RESULTS WITH THE ID NOW COVID-19 ASSAY PERFORMED ON MULTIPLE DATES ON A DIRECT TESTED NASOPHARYNGEAL KITTED SWAB. THIS IS REPORT 3 OF 4. FROM (B)(6) 2021 TO (B)(6) 2021 WE HAD ANOTHER 4 FALSE POSITIVES ID BASED ON 2 OR 3 OTHER SYSTEMS FROM PATIENTS BEING ADMITTED FOR UNRELATED COVID CONDITIONS. THE CUSTOMER REPORTED FALSE POSITIVE RESULTS WITH THE ID NOW COVID-19 ASSAY PERFORMED ON (B)(6) 2021 ON A DIRECT TESTED NASOPHARYNGEAL KITTED SWAB. CONFIRMATION TESTING WAS PERFORMED (B)(6) 2021 WITH BD MAX, THIS GENERATED NEGATIVE RESULTS. THE PATIENT RETESTED ON (B)(6) 2021 WITH BD MAX, LIAT, THIS GENERATED NEGATIVE RESULTS. THE CUSTOMER STATED THIS WAS PRE-ADMISSION TESTING ON PATIENTS WHO WERE SUSPECTED TO HAVE COVID-19. PER THE CUSTOMER THE PATIENT WAS ASYMPTOMATIC. THE CUSTOMER CONFIRMED THAT THERE WAS NO PATIENT HARM DUE TO THE TEST RESULTS. ADDITIONALLY, THE CUSTOMER CONFIRMED THERE WAS A DELAY IN TREATMENT AND IMPACT IN TREATMENT DUE TO TEST RESULTS. HOWEVER, NO ADDITIONAL INFORMATION WAS PROVIDED OTHER THAN, "INACCURATELY CHARACTERIZED AS COVID POSITIVE.." PER THE CUSTOMER, THESE CASES WERE REPORTED TO US BY INFECTION CONTROL BECAUSE SOME OF THE POTENTIAL ISSUES WITH FALSE POSITIVES INCLUDING COHORTING PATIENTS WITH TRUE POSITIVE PATIENTS, HOSPITAL STAFF CONTACT INVESTIGATIONS, UNNECESSARY STAFF TESTING, DELAY/DISRUPTION IN TREATMENT FOR NON-COVID CONDITIONS, ETC.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
574982 ID NOW COVID-19 ASSAY MOLECULAR IVD FOR ID NOW COVID-19 QJR ABBOTT DIAGNOSTICS SCARBOROUGH, INC 1023084 10811877011269

Patients

Seq Age Sex Outcome Treatment
1